Cosimo Bruno Salis

Dr. Cosimo Bruno Salis

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2025 in Life
Verified
Journal Article
Open access
PDF file
Paolo Albino FerrariPaolo Albino Ferrari
Paolo Albino Ferrari
CSCosimo Bruno Salis
Cosimo Bruno Salis
AMAntonio Macciò
Antonio Macciò
Lung cancer, the leading cause of cancer-related mortality, has brought exhaled breath condensate (EBC) into focus as a promising non-invasive sample for detecting molecular biomarkers, particularly microRNAs, which regulate gene expression and contribute to tumorigenesis. Ten key studies encompassing approximately 866 subjects consistently demonstrated distinct patterns of miRNA dysregulation in lung cancer. Notably, several reported panels achieved diagnostic sensitivity and specificity exceeding 75% through the identification of distinct miRNA signatures in EBC, with oncogenic miRNAs (e.g., miR-21) upregulated and tumor-suppressor miRNAs (e.g., miR-486) downregulated in lung cancer patients. Analytical advancements, including next-generation sequencing (NGS), have improved miRNA detection sensitivity and specificity, addressing prior limitations of low yield and variability. NGS enabled the identification of novel miRNAs and proved especially effective in overcoming the low RNA yield associated with EBC samples. However, challenges persist regarding standardization of collection, sample dilution, and potential contamination. Moreover, the reproducibility of miRNA signatures across diverse patient populations remains a critical issue. Large-scale, multicenter validation studies are needed to establish robust diagnostic algorithms integrating EBC-derived miRNAs with existing clinical tools. The potential of EBC miRNA profiling to support current screening strategies could significantly improve early lung cancer detection and patient outcomes. Nevertheless, its clinical transition requires further methodological optimization and biomarker validation. This review critically evaluates current evidence on miRNA detection in EBC for lung cancer diagnosis.

2 December 2025 in Surgeries
Verified
Journal Article
Open access
PDF file
Paolo Albino FerrariPaolo Albino Ferrari
Paolo Albino Ferrari
CSCosimo Bruno Salis
Cosimo Bruno Salis
EPElisabetta Pusceddu
Elisabetta Pusceddu
MSMassimiliano Santoru
Massimiliano Santoru
GCGianluca Canu
Gianluca Canu
AMAntonio Macciò
Antonio Macciò
Introduction: Chest drainage is central to thoracic surgery, pleural medicine, and emergency care, yet practice remains heterogeneous in tube caliber, access, suction, device selection, and removal thresholds. This narrative review aims to synthesize evidence and translate it into guidance. Materials and Methods: We performed a narrative review with PRISMA-modeled transparency. Using backward citation from recent comprehensive overviews, we included randomized trials, meta-analyses, guidelines/consensus statements, and high-quality observational studies. We extracted data on indications, technique, tube size, analog versus digital drainage, suction versus water-seal drainage, removal criteria, and key pleural conditions. Due to heterogeneity in device generations, suction targets, and outcomes, we synthesized the findings qualitatively according to converged evidence. Results: After lung resection, single-drain strategies, early use of water-seal, and standardized removal at ≤300–500 mL/day reduce pain and length of stay without increasing the need for reintervention; digital systems support objective removal using sustained low-flow thresholds (approximately 20–40 mL/min). Small-bore (≤14 Fr) Seldinger catheters perform comparably to larger tubes for secondary and primary pneumothorax and enable ambulatory pathways. In trauma, small-bore approaches can match large-bore drainage in stable patients when paired with surveillance and early escalation of care. For pleural infection, image-guided drainage, combined with fibrinolytics or surgery, is key. Indwelling pleural catheters provide relief comparable to talc in dyspnea associated with malignant effusions in patients with non-expandable lungs. Complications are mitigated by ultrasound guidance and avoiding abrupt high suction after chronic collapse; however, these strategies must be balanced against risks of malposition, occlusion or retained collections, prolonged air leaks, and device complexity, which demand protocolized escalation and team training. Conclusions: Practice coalesces around three pillars—right tube, right system, proper criteria. Adopt standardized pathways, device-agnostic thresholds, and volume or airflow criteria. Trials should harmonize “seal” definitions and validate telemetry-informed removal strategies.

9 June 2026 in Journal of Respiration
Verified
Journal Article
Open access
PDF file
CSCosimo Bruno Salis
Cosimo Bruno Salis
Paolo Albino FerrariPaolo Albino Ferrari
Paolo Albino Ferrari
SSSabrina Sarais
Sabrina Sarais
AMAntonio Macciò
Antonio Macciò
Alessandro FoisAlessandro Fois
Alessandro Fois
Background: Medical thoracoscopy (MT) represents the gold standard for undiagnosed pleural effusions, traditionally performed in the presence of pleural fluid. Recent technical advances have enabled MT in “dry space” conditions (minimal or absent pleural effusion), raising questions about comparative diagnostic efficacy and safety profiles. Objective: This literature review aims to evaluate diagnostic yield and complication rates between traditional MT performed in patients with current pleural effusion and dry medical thoracoscopy (DMT). Results: MT demonstrates diagnostic sensitivity ranging from 80% to 96.3% and specificity close to 100% for malignant pleural disease, and the diagnostic accuracy is 99.1% for tuberculous pleuritis. DMT’s recent studies report optimal success rates in pleural access and tissue sampling, and diagnostic sensitivity for malignancy up to 100%, although a confirmation with larger cohorts for technique comparison is needed. Major complication rates are comparable between MT and DMT, with no significant differences in overall adverse events. Mortality rates remain exceptionally low (≤0.1%) for both approaches. Conclusions: MT remains a highly effective diagnostic tool for pleural diseases. DMT represents a valid and safe alternative in patients without significant pleural effusion, although technically more demanding, and further studies are required to validate the technique.

28 August 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
Paolo Albino FerrariPaolo Albino Ferrari
Paolo Albino Ferrari
CSCosimo Bruno Salis
Cosimo Bruno Salis
SSSabrina Sarais
Sabrina Sarais
MSMassimiliano Santoru
Massimiliano Santoru
MPMatteo Pinna-Susnik
Matteo Pinna-Susnik
AMAntonio Macciò
Antonio Macciò
Background/Objectives: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) can be performed via pathways that differ in anesthesia, setting, airway management, monitoring, recovery, and hospitalization. We compared an outpatient endoscopy suite pathway with sedation and spontaneous breathing, and an operating room pathway with general anesthesia and laryngeal mask ventilation, assessing cytology-based yield, sample adequacy, workflow, and costs. Methods: This single-center observational study included consecutive EBUS-TBNA procedures. Allocation was nonrandom and reflected workflow, operating room availability, complexity, airway/anesthetic considerations, and judgment. The primary endpoint was cytology-based diagnostic yield in the diagnostic cohort; staging outcomes included cytology distribution, sample adequacy, and positivity among adequate samples. Systematic diagnostic verification was not available for the entire cohort; however, postoperative nodal pathology was retrospectively retrieved when available in the staging cohort. Because verification remained incomplete and selectively available, sensitivity, specificity, negative predictive value, and overall diagnostic accuracy were not estimated. Results: Clinical outcome analyses included 447 procedures (319 diagnostic and 128 staging), while the administrative cost dataset included 533 completed procedures. Diagnostic yield was similar between pathways (108/229, 47.2% vs. 45/90, 50.0%; p = 0.740). In the staging cohort, sample adequacy was comparable (83/85, 97.6% vs. 39/42, 92.9%; p = 0.331), and positivity among adequate samples did not differ (21.7% vs. 20.5%; p = 1.000). Exploratory postoperative pathological nodal-stage data were available for 60/128 staging procedures; among 58 cases with interpretable EBUS-TBNA results, patient-level N-stage concordance was 44/58 (75.9%), and postoperative nodal upstaging occurred in 11/58 (19.0%). No prespecified intraprocedural composite adverse events were documented. Duration appeared shorter in operating room cases but, owing to incomplete differential recording, was descriptive only. Length of stay and costs were markedly higher in the operating room pathway. Conclusions: The pathways showed similar cytology-based outcomes but differed in hospitalization rates and costs. Nonrandom allocation and pathway heterogeneity preclude causal interpretation as a sedation-versus-general-anesthesia comparison. Prospective studies with standardized allocation, diagnostic verification, systematic capture of adverse events, and follow-up are warranted.

10 April 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
CSCosimo Bruno Salis
Cosimo Bruno Salis
Paolo Albino FerrariPaolo Albino Ferrari
Paolo Albino Ferrari
SSSabrina Sarais
Sabrina Sarais
AMAntonio Macciò
Antonio Macciò
Alessandro FoisAlessandro Fois
Alessandro Fois
Background: Medical thoracoscopy (MT) represents the gold standard for undiagnosed pleural effusions, traditionally performed in the presence of pleural fluid. Recent technical advances have enabled MT in "dry space" conditions (minimal or absent pleural effusion), raising questions about comparative diagnostic efficacy and safety profiles. Objective: This literature review aims to evaluate diagnostic yield and complication rates between traditional MT performed in patients with current pleural effusion and dry medical thoracoscopy (DMT). Results: MT demonstrates diagnostic sensitivity ranged from 80% to 96.3% and specificity close to 100% for malignant pleural disease and diagnostic accuracy is 99.1% for tuberculous pleuritis. DMT using ultrasound guidance achieves comparable diagnostic yield, with recent studies reporting optimal success rates in pleural access and tissue sampling, and diagnostic sensitivity for malignancy up to 100%. Major complication rates are comparable between MT and DMT, with no significant differences in overall adverse events. Mortality rates remain exceptionally low (≤0.1%) for both approaches. Conclusions: MT remains a highly effective diagnostic tool for pleural diseases. DMT represents a valid and safe alternative in patients without significant pleural effusion, offering comparable diagnostic yield. Although technically more demanding, DMT expands diagnostic possibilities in selected clinical scenarios.